Insider track record
OtherAcross 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Fry Hannah. Director active across 1 company, notably Protara Therapeutics, Inc.. Aggregated, 9 reports have been logged. History available since 16 July 2022. The latest transaction was disclosed on 24 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
9,500 shares0Common StockSEC:0001213900-25-007531:0
2,130 shares@ US$4.7626.6% of flowCommon StockSEC:0001213900-25-005964:0
394 shares@ US$6.146.4% of flowCommon StockSEC:0001213900-25-001645:0
8,000 shares0Common StockSEC:0001213900-24-005722:0
324 shares@ US$2.171.8% of flowCommon StockSEC:0001213900-24-001512:0
10,075 shares@ US$2.5662.7% of flowCommon StockSEC:0001213900-23-057844:0
5,900 shares0Common StockSEC:0001213900-23-004080:0
361 shares@ US$2.802.6% of flowCommon StockSEC:0001213900-23-000853:0
25,000 shares0Common StockSEC:0001213900-22-040288:0